Search results for "Regulatory"

showing 10 items of 740 documents

Death receptors as targets in cancer

2013

Anti-tumour therapies based on the use PARAs (pro-apoptotic receptor agonists), including TRAIL (TNF-Related Apoptosis inducing Ligand) or monoclonal antibodies targeting TRAIL-R1 or TRAIL-R2, have been disappointing so far, despite clear evidence of clinical activity and lack of adverse events for the vast majority of these compounds, whether combined or not with conventional or targeted anti-cancer therapies. This brief review aims at discussing the possible reasons for the lack of apparent success of these therapeutic approaches and at providing hints in order to rationally design optimal protocols based on our current understanding of TRAIL signalling regulation or resistance for future…

Pharmacology0303 health sciencesTumor targetingmedicine.drug_classCancerTNF-Related Apoptosis-Inducing LigandBiologyMonoclonal antibodyApoptosis Regulatory ProteinsBioinformaticsmedicine.disease3. Good healthClinical trial03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisImmunologymedicineDeath ReceptorsAdverse effect030304 developmental biologyBritish Journal of Pharmacology
researchProduct

Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B

2014

Treatment of glioblastoma multiforme (GBM), the most common and aggressive lethal brain tumor, represents a great challenge. Despite decades of research, the survival prognosis of GBM patients is unfavorable and more effective therapeutics are sorely required. Archazolid B, a potent vacuolar H(+)-ATPase inhibitor influencing cellular pH values, is a promising new compound exerting cytotoxicity in the nanomolar range on wild-type U87MG glioblastoma cells and U87MG.∆EGFR cells transfected with a mutant epidermal growth factor receptor (EGFR) gene. Gene expression profiling using microarray technology showed that archazolid B caused drastic disturbances in cholesterol homeostasis. Cholesterol,…

PharmacologyCholesterolTransfectionBiologyToxicologyUp-RegulationSterol regulatory element-binding proteinGene expression profilingThiazoleschemistry.chemical_compoundCholesterolDownregulation and upregulationBiochemistrychemistryDrug Resistance NeoplasmCell Line TumorLDL receptorCancer researchbiology.proteinHumansV-ATPaselipids (amino acids peptides and proteins)MacrolidesEpidermal growth factor receptorGlioblastomaToxicology and Applied Pharmacology
researchProduct

Transcriptional regulation and expression of CYP3A4 in hepatocytes.

2007

CYP3A4 is the most abundantly expressed drug-metabolizing P450 enzyme in human liver and contributes to the metabolism of a large number of drugs in use today. CYP3A4 is constitutively expressed in adult hepatocytes but it can also be transcriptionally induced by a variety of structurally diverse xenochemicals. CYP3A4 strongly contributes to the important variability in the therapeutic and toxic effects of drugs owing to the major role it plays in xenobiotic metabolism and the large intra- and inter-individual variability to which it is subjected. The functional examination of up to 13 kb of the CYP3A4 5'-flanking region has revealed that the regulation of this gene is a complex issue, with…

PharmacologyRegulation of gene expressionPregnane X receptorTranscription GeneticClinical BiochemistryDown-RegulationBiologyPharmacologyRegulatory Sequences Nucleic AcidGene Expression Regulation EnzymologicCell biologyDrug developmentNuclear receptorCytochrome P-450 Enzyme SystemLiverRegulatory sequenceTranscriptional regulationHepatocytesAnimalsCytochrome P-450 CYP3AHumansTranscription factorDrug metabolismCurrent drug metabolism
researchProduct

Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials

2007

In clinical trials a periodical check of safety and efficacy data is often needed. For organizational reasons it is rarely desirable to stop a trial during such an interim analysis. Therefore, new study patients are included in the trial while the interim analysis is ongoing. Disregarding the additional information provided by these interim patients would be unsatisfactory, especially for an office of regulatory affairs. Consequently, the rules for group sequential or adaptive decisions must be adjusted to the recruitment of interim patients. In this paper, two strategies for modifying study designs to consider the analysis of interim patients are proposed.

PharmacologyStatistics and ProbabilityResearch designClinical Trials as TopicOperations researchbusiness.industryClinical study designMEDLINEInterim analysismedicine.diseaseRegulatory affairsClinical trialResearch DesignSample size determinationSample Sizehealth services administrationInterimmedicineHumansPharmacology (medical)Medical emergencybusinesshealth care economics and organizationsJournal of Biopharmaceutical Statistics
researchProduct

In Vitro Analysis of the Two-Component System MtrB-MtrA from Corynebacterium glutamicum▿ †

2007

ABSTRACT The two-component system MtrBA is involved in the osmostress response of Corynebacterium glutamicum . MtrB was reconstituted in a functionally active form in liposomes and showed autophosphorylation and phosphatase activity. In proteoliposomes, MtrB activity was stimulated by monovalent cations used by many osmosensors for the detection of hypertonicity. Although MtrB was activated by monovalent cations, they lead in vitro to a general stabilization of histidine kinases and do not represent the stimulus for MtrB to sense hyperosmotic stress.

PhosphataseCorynebacteriumEnzyme ActivatorsMicrobiologyCorynebacterium glutamicumEnzyme activatorBacterial ProteinsOsmotic PressurePhosphorylationMolecular BiologyHistidinebiologyAutophosphorylationRNA-Binding ProteinsCations Monovalentbiology.organism_classificationAdaptation PhysiologicalTwo-component regulatory systemPhosphoric Monoester HydrolasesCorynebacterium glutamicumBiochemistryLiposomesPhosphorylationATP-Binding Cassette TransportersSignal TransductionTranscription Factors
researchProduct

Bax Inhibitor-1-mediated Ca2+ leak is decreased by cytosolic acidosis

2013

Bax Inhibitor-1 (BI-1) is an evolutionarily conserved six-transmembrane domain endoplasmic reticulum (ER)-localized protein that protects against ER stress-induced apoptotic cell death. This function is closely connected to its ability to lower steady-state ER Ca2+ levels. Recently, we elucidated BI-1's Ca(2+)-channel pore in the C-terminal part of the protein and identified the critical amino acids of its pore. Based on these insights, a Ca(2+)-channel pore-dead mutant BI-1 (BI-1(D213R)) was developed. We determined whether BI-1 behaves as a bona fide H+/Ca2+ antiporter or as an ER Ca(2+)-leak channel by investigating the effect of pH on unidirectional Ca(2+)-efflux rates. At pH 6.8, wild-…

PhysiologyAntiporterMutantApoptosisPeptideEndoplasmic ReticulumCell LineMiceAspartic acidAnimalsHumansMolecular BiologyCalcimycinchemistry.chemical_classificationBAX inhibitor 1ChemistryEndoplasmic reticulumMembrane ProteinsCell BiologyHydrogen-Ion ConcentrationProtein Structure TertiaryAmino acidCell biologyCytosolBiophysicsCalciumAcidosisApoptosis Regulatory ProteinsPeptidesHeLa CellsCell Calcium
researchProduct

TLR4 abrogates the Th1 immune response through IRF1 and IFN-β to prevent immunopathology during L. infantum infection

2020

A striking feature of human visceral leishmaniasis (VL) is chronic inflammation in the spleen and liver, and VL patients present increased production levels of multiple inflammatory mediators, which contribute to tissue damage and disease severity. Here, we combined an experimental model with the transcriptional profile of human VL to demonstrate that the TLR4-IFN-β pathway regulates the chronic inflammatory process and is associated with the asymptomatic form of the disease. Tlr4-deficient mice harbored fewer parasites in their spleen and liver than wild-type mice. TLR4 deficiency enhanced the Th1 immune response against the parasite, which was correlated with an increased activation of de…

PhysiologyGene ExpressionWhite Blood CellsMiceCell SignalingAnimal CellsImmune PhysiologyZoonosesImmunopathologyMedicine and Health SciencesMembrane Receptor SignalingBiology (General)Immune ResponseLeishmaniasisProtozoansLeishmaniaMice Knockout0303 health sciencesbiologyT Cells030302 biochemistry & molecular biologyEukaryotaImmune Receptor SignalingInfectious Diseasesmedicine.anatomical_structureLeishmaniasis VisceralCellular Typesmedicine.symptomLeishmania infantumResearch ArticleSignal TransductionNeglected Tropical DiseasesQH301-705.5Leishmania InfantumImmune CellsImmunologySpleenInflammationLEISHMANIOSE VISCERALMicrobiology03 medical and health sciencesImmune systemVirologyParasitic DiseasesGeneticsmedicineAnimalsMolecular Biology030304 developmental biologyInflammationProtozoan InfectionsBlood CellsOrganismsBiology and Life SciencesCell BiologyInterferon-betaTh1 CellsRC581-607Tropical Diseasesmedicine.diseasebiology.organism_classificationParasitic ProtozoansToll-Like Receptor 4IRF1Visceral leishmaniasisImmunologyTLR4ParasitologyImmunologic diseases. AllergySpleenInterferon Regulatory Factor-1
researchProduct

Polycomb-like 2 Associates with PRC2 and Regulates Transcriptional Networks during Mouse Embryonic Stem Cell Self-Renewal and Differentiation

2010

SummaryPolycomb group (PcG) proteins are conserved epigenetic transcriptional repressors that control numerous developmental gene expression programs and have recently been implicated in modulating embryonic stem cell (ESC) fate. We identified the PcG protein PCL2 (polycomb-like 2) in a genome-wide screen for regulators of self-renewal and pluripotency and predicted that it would play an important role in mouse ESC-fate determination. Using multiple biochemical strategies, we provide evidence that PCL2 is a Polycomb Repressive Complex 2 (PRC2)-associated protein in mouse ESCs. Knockdown of Pcl2 in ESCs resulted in heightened self-renewal characteristics, defects in differentiation, and alte…

Pluripotent Stem CellsCellular differentiationGene regulatory networkDown-RegulationPolycomb-Group Proteinsmacromolecular substancesMethylationBiochemistryArticleCell LineHistonesSelf-RenewalMice03 medical and health sciences0302 clinical medicineEmbryonic Stem CellHistone methylationPolycomb-group proteinsGeneticsAnimalsGene Regulatory NetworksEpigeneticsInduced pluripotent stem cellEmbryonic Stem Cells030304 developmental biologyGenetics0303 health sciencesbiologyurogenital systemGene Expression ProfilingPolycomb Repressive Complex 2Cell DifferentiationCell BiologyCellular ReprogrammingSTEMCELLPRC2Embryonic stem cellRepressor ProteinsOncologyDifferentiation030220 oncology & carcinogenesisembryonic structuresbiology.proteinMolecular MedicineTranscriptional NetworkPRC2Genome-Wide Association StudyProtein BindingCell Stem Cell
researchProduct

Trade and Interlegality

2019

The idea that the WTO legal system and its institutional bodies (especially the judicial branch) have developed a single-sided ides of what is good and would attempt to impose a deep-rooted liberalization agenda on the rest of world is hardly corroborated by an empirical analysis. Quite the contrary, recourse to a series of legal techniques has made it possible to leave open a space for reciprocal understanding and debate with other circuits of legality.

Political scienceWTO reciprocity direct effect deep liberalization contestation interpretation domestic regulatory autonomy interlegalityIUS/13 - DIRITTO INTERNAZIONALEPrinciple of legalityWTO interlegality Appellate Body interpretation direct effectComputingMilieux_MISCELLANEOUSLaw and economics[SHS]Humanities and Social Sciences
researchProduct

The Regulatory State vs. the Networked Polity: confronting narratives of change

2014

The aim of the article is to summarize and reassess the innovations brought about by governance theory. It is argued that the notion of governance is a conceptual device that could help rationalise and articulate the changes undertaken by liberal democracies since the late 1970s. The article suggests the need to distinguish between two distinct research programmes composing governance studies, which are influenced by alternative epistemic traditions—political economy and economic sociology. Rationalizations of change influenced by political economy support the idea that the outcome of recent political change is a market-oriented “Regulatory State”, while those influence by economic sociolog…

Power (social and political)Economic sociologyPolitical scienceCorporate governanceRegulatory stategovernance regulation regulatory state networked polityNormativeNarrativeGeneral MedicinePolityLiberal democracyPositive economicsSocial science
researchProduct